Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus Patients

Exclusion Criteria

• •Patients with type 1 diabetes mellitus (T1DM).
• •Nightshift worker.
• •Female patients who are pregnant or lactating.
• •Treatment with an insulin other than basal insulin (premixes, rapid insulin, fast acting insulin analogues) within the previous 3 months.
• •Patients with less than 1 year history of diabetes.
• •Patients unwilling to inject insulin or perform self-monitoring blood glucose.
• •Current alcohol or drug abuse.
• •Patients unlikely to comply with the protocol and complete the study eg, uncooperative attitude, inability to return for follow-up visits.
• •Patients with active cancer or any other diseases or conditions which in the opinion of the Investigator would make the patient unsuitable for participation in the study.
• •Any clinically significant laboratory findings that in the judgment of the Investigator would preclude safe completion of the study.
• •Known allergies to study drugs.
• •Participation in another clinical study.
• •The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.